David Lee
David Lee, PhD, earned a BSc in Neuroscience from University College Cork (UCC), a PhD in Neuroscience from Trinity College Dublin (TCD), and Postgraduate Certificates in Innovation, Entrepreneurship, and Statistics, also from TCD. His research has focused on neurodegenerative diseases, metabolic influences on neural development, and therapeutic applications in Parkinson’s disease.
David currently serves as the Market Expansion & Partner Engagement Manager at Assay Genie.
Connect with David or explore his work:
Recent Blogs by David:
Introduction to IL-10R and Immune Suppression in CancerThe interleukin-10 receptor (IL-10R) is a key player in regulating immune responses, particularly in suppressing inflammation and maintaining immune tolerance. IL-10R is activated by its ligand, interleukin-10 (IL-10), an anti-inflammatory cytokine that is critical in controlling [...]
Amino acids are the fundamental units of proteins, playing critical roles in virtually every biological process. Composed of a central carbon atom bonded to an amino group (-NHâ‚‚), a carboxyl group (-COOH), a hydrogen atom, and a unique side chain (R-group), amino acids [...]
Treponema pallidum, the causative agent of syphilis, triggers an immune response that produces antibodies detectable by laboratory tests. Diagnosing syphilis often involves detecting these antibodies through serological tests, which are categorized as non-treponemal and treponemal. Each type of test has unique features that [...]
Publications by David:
Additional Resources
